ribavirin has been researched along with Cochlear Hearing Loss in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akin, H; Atug, O; Sari, M; Tozun, N; Yilmaz, Y | 1 |
Karatapanis, S; Lisgos, P; Papastergiou, V; Skorda, L | 1 |
Cheong-Lee, C; Ford, JA; Wong, VK; Yoshida, EM | 1 |
Berkan, E; Jozefowicz-Korczynska, M; Piekarska, A; Wojcik, K | 1 |
4 other study(ies) available for ribavirin and Cochlear Hearing Loss
Article | Year |
---|---|
Pegylated interferon/ribavirin-induced sudden sensorineural hearing loss in a patient with chronic hepatitis C.
Topics: Antiviral Agents; Audiometry, Pure-Tone; Drug Therapy, Combination; Hearing Loss, Sensorineural; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2009 |
Reversible sudden sensorineural hearing loss during chronic hepatitis C treatment with pegylated interferon/ribavirin.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Hearing Loss, Sensorineural; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2011 |
Acute sensorineural hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment: outcome after resumption of therapy.
Topics: Acute Disease; Antiviral Agents; Drug Therapy, Combination; Female; Hearing Loss, Sensorineural; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2005 |
Sudden hearing loss in chronic hepatitis C patient suffering from Turner syndrome, treated with pegylated interferon and ribavirin.
Topics: Adult; Antiviral Agents; Audiometry, Pure-Tone; Disease Progression; Drug Therapy, Combination; Female; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Severity of Illness Index; Turner Syndrome | 2007 |